Fisher & Paykel Healthcare Co. Limited (ASX:FPH) Insider Graham McLean Buys 1,000 Shares

Fisher & Paykel Healthcare Co. Limited (ASX:FPHGet Free Report) insider Graham McLean purchased 1,000 shares of Fisher & Paykel Healthcare stock in a transaction on Monday, February 17th. The stock was bought at an average price of A$32.30 ($20.57) per share, with a total value of A$32,300.00 ($20,573.25).

Fisher & Paykel Healthcare Stock Performance

The company has a current ratio of 1.83, a quick ratio of 0.79 and a debt-to-equity ratio of 10.75. The stock has a market capitalization of $20.55 billion, a PE ratio of 157.79, a PEG ratio of 4.47 and a beta of 0.42.

Fisher & Paykel Healthcare Increases Dividend

The company also recently declared a Interim dividend, which was paid on Tuesday, December 17th. Shareholders of record on Tuesday, December 17th were issued a $0.167 dividend. The ex-dividend date of this dividend was Wednesday, December 4th. This represents a yield of 0.49%. This is a positive change from Fisher & Paykel Healthcare’s previous Interim dividend of $0.17. Fisher & Paykel Healthcare’s dividend payout ratio is presently 180.95%.

Fisher & Paykel Healthcare Company Profile

(Get Free Report)

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital.

Further Reading

Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.